A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies
K. H. Dinnon, S. R. Leist, K. Okuda, H. Dang, E. J. Fritch, K. L. Gully, G. Cruz, M. D. Evangelista, T. Asakura, R. C. Gilmore, P. Hawkins, S. Nakano, A. West, A. Schäfer, L. E. Gralinski, , Montg
This paper develops a murine model of persistent post-SARS-CoV-2 lung disease to identify therapeutic targets and test interventions for PASC.
bioRxiv · Feb 15, 2022 · PreprintMicrobiology